Impact of pulmonary endarterectomy (PEA) on quality of life as assessed by CAMbridge Pulmonary Hypertension Outcome Review (CAMPHOR) Source: Eur Respir J 2006; 28: Suppl. 50, 403s Year: 2006
Portuguese validation of the Cambridge pulmonary hypertension outcome review (CAMPHOR) questionnaire Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014
Development and first validation of the COPD Assessment Test Source: Eur Respir J 2009; 34: 648 Year: 2009
Studying quality of life in PAH: Patient-reported outcome assessment and psychosocial evaluation in a 6 months follow-up Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014
Reliability and validity of TAPQOL questionnaire for the assessment of global health related quality of life (HRQL) in children with Paediatric Central Airway Obstructive Disease (PCAOD) Source: International Congress 2017 – Paediatric bronchology in clinical practice Year: 2017
Examination about what determine quality of life (QOL) and the association between QOL and therapeutic intervention for patients with chronic thromboembolitic pulmonary hypertension (CTEPH) Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014
Responsiveness of cambridge pulmonary hypertension outcome review (CAMPHOR) scores and utility in pulmonary hypertension (PH) patients Source: Eur Respir J 2007; 30: Suppl. 51, 343s Year: 2007
Quality of life of idiopathic pulmonary fibrosis patients Source: Eur Respir J 2001; 17: 954-961 Year: 2001
Development and validation of the Adolescent Asthma Quality of Life Questionnaire (AAQOL) Source: Eur Respir J 2001; 17: 52-58 Year: 2001
Timed Up & Go test in COPD: Changes over time, validity and responsiveness to pulmonary rehabilitation Source: International Congress 2014 – Latest insights in pulmonary rehabilitation Year: 2014
Responsiveness of the clinical COPD questionaire to pulmonary rehabilitation Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation Year: 2013
Correlations between clinical variables and quality of life in pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014
Functional independence, symptoms, quality of life and emotional responses after pulmonary rehabilitation in COPD Source: International Congress 2014 – Best posters in pulmonary rehabilitation 1 Year: 2014
EmPH asis-10 is associated with clinical outcome measures in pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013
Impact of riociguat on health-related quality of life (HRQoL) in patients with pulmonary arterial hypertension (PAH) Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013
Translation, validity and reliability of the Leicester cough questionnaire into Swedish in COPD Source: International Congress 2016 – Physiotherapy management of the ill but spontaneously-breathing adult patient Year: 2016
Impact of gender on disease activity, pulmonary function and health status in sarcoidosis patients – King’s sarcoidosis questionnaire (KSQ) Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases Year: 2013
Physical activity (PA) in pulmonary arterial hypertension (PAH) can be predicted by questionnaire Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016
Correlations between the German versions of the clinical COPD questionnaire (CCQ), COPD assessment test (CAT) and the St George respiratory questionnaire (SGRQ) Source: International Congress 2014 – Management of COPD in primary care Year: 2014
Health-related quality of life in COPD: why both disease-specific and generic measures should be used Source: Eur Respir J 2001; 18: 69-76 Year: 2001